Lactobacillus Reuteriand Inflammation.
Evidence gradeA
ImpactModerate
Confidencehigh
Imported rating. This grade comes from SuppCo and has not been independently reviewed. It describes research, not a product, and it is not medical advice.
The rating
- Direction
- Favourable
- Rated by
- SuppCo
- Observed
- 28 September 2026
Studies behind it
The role of potential probiotic strains Lactobacillus reuteri in various intestinal diseases: New roles for an old playerZihan YuLactobacillus reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR StudyC. Tenorio-Jiménez · Nutrients2019The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel diseaseHuiyu Wang